Mr. Am Gill reports

BIOSENTA BUILDS ON PARTNERSHIP WITH AMPAK TO TEST AND COMMERCIALIZE TRI-FILLER(TM)

Biosenta Inc. has entered the next level of its partnership with Ampak Inc. and the University of Calgary. The new agreement will see Tri-Filler being tested in plastics at Ampak facilities with an eye to commercialization.

Further to the announcement of the partnership on Sept. 24, 2020, Ampak has signed a new agreement with Biosenta and the University of Calgary that will go through to May, 2025. The agreement includes financing research intended to develop and prove Tri-Filler for use in plastics. Ampak will also be concurrently developing processes for use of Tri-Filler in its own production facilities.

"The new agreement is in response to the successful results of the Tri-Filler research conducted by the University of Calgary," said Am Gill, president and chief executive officer of Biosenta. "This would make Ampak Inc. the first company to have anti-microbial components in the production of plastic materials."

Ampak is proud to have been the first industry research partner to commit to this project. "We are excited to be on the forefront of research in the development of our products with Tri-Filler. This will be a game changer in the production of plastic materials and human health," said Salvatore Nicastro, president of Ampak.

Biosenta continues discussions with additional industry partners in cement and paint, to leverage this innovation and test Tri-Filler in their production processes in addition to Ampak.

About Biosenta Inc.

Biosenta, a groundbreaking pioneer in the field of anti-microbial solutions, is on a mission to revolutionize the material world. The company develops cutting-edge chemical compounds designed to eliminate harmful microorganisms such as bacteria, fungi and viruses for household and industrial uses, while ensuring safety for both humans and the environment. Biosenta's aim is to address the escalating global health crisis of anti-microbial resistance (AMR).

We seek Safe Harbor.